Molecular testing for advanced head and neck cancer
Part of Cancer clinical trials.
This trial is for people with head and neck cancer that has not spread to distant parts of the body. It is a non-treatment study that will look at the molecular features of your tumor from a biopsy sample to help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of squamous cell carcinoma in the head or neck area, specifically in the mouth, throat, voice box, or lower throat.
- Your cancer must be locally advanced (stage T1N1M0 to T4N3M0), meaning it has spread to nearby lymph nodes but not to distant parts of the body.
- A tissue sample from your biopsy must be available for testing.
- You cannot have another active cancer at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and tumor tissue samples to analyze biological markers in patients with advanced head and neck squamous cell carcinoma before starting immunotherapy. The goal is to better understand how these markers relate to treatment response.
This study looks at specific genetic “methylation” patterns in people with head and neck squamous cell carcinoma. The results may help doctors understand the disease better and identify who may benefit from future treatments.
This study looks at head and neck tumors using molecular and genetic tests. It may help doctors learn more about what drives different tumors and how they might respond to treatment, using biopsy or stored tumor tissue.
This trial is collecting information and blood samples from people with head and neck cancer that cannot be cured. It aims to learn more about the cancer and find better ways to treat it.
This study uses tumor tissue taken from people with head and neck cancer, then grows it in a lab to better understand the cancer and predict responses. If you have a new or returning cancer and can share key medical details and follow-up information, you may be able to take part.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.